Prognostic factors and prevention of radioembolization-induced liver disease
Hepatology2012Vol. 57(3), pp. 1078–1087
Citations Over TimeTop 10% of 2012 papers
Belén Gil-Alzugaray, Á. Chopitea, Mercedes Iñarrairaegui, José Ignacio Bilbao, Macarena Rodríguez‐Fraile, Javier Rodríguez, Alberto Benito, Inés Dominguez, Delia D’Avola, J.I. Herrero, Jorge Quiroga, Jesús Prìeto, Bruno Sangro
Abstract
REILD is an uncommon but relevant complication that appears when liver tissue primed by cirrhosis or prior and subsequent chemotherapy is exposed to the radiation delivered by radioactive microspheres. We designed a comprehensive treatment protocol that reduces the frequency and the severity of REILD.
Related Papers
- → Ursodeoxycholic acid inhibits the induction of nitric oxide synthase(1996)20 cited
- → Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy(2000)9 cited
- Application of ursodeoxycholic acid for the treatment of cholestatic liver diseases(2008)
- [Ursodeoxycholic acid in primary biliary cirrhosis. 1: Therapeutic approaches up to now and the rationale for treatment with ursodeoxycholic acid].(1988)
- → Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a summary of the PITCHES study and its clinical implications(2020)